JP2023517671A5 - - Google Patents
Info
- Publication number
- JP2023517671A5 JP2023517671A5 JP2022554769A JP2022554769A JP2023517671A5 JP 2023517671 A5 JP2023517671 A5 JP 2023517671A5 JP 2022554769 A JP2022554769 A JP 2022554769A JP 2022554769 A JP2022554769 A JP 2022554769A JP 2023517671 A5 JP2023517671 A5 JP 2023517671A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989041P | 2020-03-13 | 2020-03-13 | |
| US62/989,041 | 2020-03-13 | ||
| PCT/US2021/022090 WO2021183873A1 (en) | 2020-03-13 | 2021-03-12 | Sequential treatment of cancers using 6-thio-dg, checkpoint inhibitors and radiation therapy |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023517671A JP2023517671A (ja) | 2023-04-26 |
| JP2023517671A5 true JP2023517671A5 (https=) | 2024-03-05 |
| JPWO2021183873A5 JPWO2021183873A5 (https=) | 2024-03-05 |
| JP7829491B2 JP7829491B2 (ja) | 2026-03-13 |
Family
ID=77671975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554769A Active JP7829491B2 (ja) | 2020-03-13 | 2021-03-12 | ６－チオ－ｄＧ、チェックポイント阻害剤および放射線療法を使用するがんの逐次処置 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12097213B2 (https=) |
| EP (1) | EP4117667B1 (https=) |
| JP (1) | JP7829491B2 (https=) |
| KR (1) | KR20220154134A (https=) |
| CN (1) | CN115397428A (https=) |
| AU (1) | AU2021233023B2 (https=) |
| BR (1) | BR112022018238A2 (https=) |
| CA (1) | CA3170930A1 (https=) |
| DK (1) | DK4117667T3 (https=) |
| ES (1) | ES3014683T3 (https=) |
| FI (1) | FI4117667T3 (https=) |
| HU (1) | HUE070513T2 (https=) |
| IL (1) | IL296403A (https=) |
| MX (1) | MX2022011331A (https=) |
| PL (1) | PL4117667T3 (https=) |
| PT (1) | PT4117667T (https=) |
| WO (1) | WO2021183873A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019183482A1 (en) | 2018-03-22 | 2019-09-26 | The Board Of Regents Of The University Of Texas System | USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS |
| WO2025090539A1 (en) * | 2023-10-22 | 2025-05-01 | Regeneron Pharmaceuticals, Inc. | Treatment of non-small cell lung cancer with 6-thio-dg and cemiplimab |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012052181A1 (en) * | 2010-10-22 | 2012-04-26 | Roche Diagnostics Gmbh | A conjugate between a thiophilic solid phase and an oligonucleotide comprising a thiooxonucleotide |
| CA2907924C (en) | 2013-04-08 | 2022-10-25 | The Board Of Regents Of The University Of Texas System | Telomerase mediated telomere altering compounds |
| CN116059219A (zh) * | 2015-07-16 | 2023-05-05 | 比奥克斯塞尔医疗股份有限公司 | 一种使用免疫调节治疗癌症的新颖方法 |
| US20180036331A1 (en) | 2016-03-24 | 2018-02-08 | The Board Of Regents Of The University Of Texas System | Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds |
| EP3463370A4 (en) * | 2016-05-27 | 2020-04-08 | The Board of Regents of The University of Texas System | 6-THIO-2'-DEOXYGUANOSINE (6-THIO-DG) RESULTS IN TELOMERASE-DEPENDENT TELOMER DYS FUNCTION AND CELL DEATH IN THERAPY-RESISTANT CANCER CELL |
| KR20190053909A (ko) | 2016-09-16 | 2019-05-20 | 바이오노믹스 리미티드 | 항체와 체크포인트 면역 억제제의 병용 요법 |
| KR20240011262A (ko) * | 2017-02-21 | 2024-01-25 | 리제너론 파아마슈티컬스, 인크. | 폐암의 치료를 위한 항-pd-1 항체 |
| JP2020515637A (ja) | 2017-04-03 | 2020-05-28 | オンコロジー、インコーポレイテッド | 免疫腫瘍剤を伴うｐｓ標的化抗体を用いる癌の治療方法 |
| WO2019152574A1 (en) * | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-lag3 antibody, and an anti-tigit antibody |
| US20210113602A1 (en) | 2018-02-28 | 2021-04-22 | The Board Of Regents Of The University Of Texas System | USE OF 6-THIO-2'-DEOXYGUANOSINE (6-THIO-dG) TO TREAT MELANOMA |
| WO2019183482A1 (en) * | 2018-03-22 | 2019-09-26 | The Board Of Regents Of The University Of Texas System | USE OF 6-THIO-dG TO TREAT THERAPY-RESISTANT TELOMERASEPOSITIVE PEDIATRIC BRAIN TUMORS |
-
2021
- 2021-03-12 BR BR112022018238A patent/BR112022018238A2/pt unknown
- 2021-03-12 HU HUE21767125A patent/HUE070513T2/hu unknown
- 2021-03-12 JP JP2022554769A patent/JP7829491B2/ja active Active
- 2021-03-12 PL PL21767125.4T patent/PL4117667T3/pl unknown
- 2021-03-12 FI FIEP21767125.4T patent/FI4117667T3/fi active
- 2021-03-12 IL IL296403A patent/IL296403A/en unknown
- 2021-03-12 DK DK21767125.4T patent/DK4117667T3/da active
- 2021-03-12 MX MX2022011331A patent/MX2022011331A/es unknown
- 2021-03-12 PT PT217671254T patent/PT4117667T/pt unknown
- 2021-03-12 US US17/200,539 patent/US12097213B2/en active Active
- 2021-03-12 CN CN202180028952.2A patent/CN115397428A/zh active Pending
- 2021-03-12 AU AU2021233023A patent/AU2021233023B2/en active Active
- 2021-03-12 KR KR1020227033906A patent/KR20220154134A/ko active Pending
- 2021-03-12 CA CA3170930A patent/CA3170930A1/en active Pending
- 2021-03-12 EP EP21767125.4A patent/EP4117667B1/en active Active
- 2021-03-12 ES ES21767125T patent/ES3014683T3/es active Active
- 2021-03-12 WO PCT/US2021/022090 patent/WO2021183873A1/en not_active Ceased
-
2024
- 2024-09-09 US US18/829,162 patent/US20240424013A1/en active Pending